期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Using Tree Shrews (Tupaia belangeri)as a Novel Animal Model of Liver Transplantation 被引量:4
1
作者 Bo TANG Tao WU +7 位作者 Shu-feng XIAO Jia-yun GE Dong WEI chun-man li Qiu-hong WANG Wang ZENG Bi-mang FU Jie ZHANG 《Current Medical Science》 SCIE CAS 2018年第6期1069-1074,共6页
Liver transplantation (LT)is most effective and promising approach for end-stage liver disease.However,there remains room for further improvement and innovation,for example, to reduce ischemic reperfusion injury,trans... Liver transplantation (LT)is most effective and promising approach for end-stage liver disease.However,there remains room for further improvement and innovation,for example, to reduce ischemic reperfusion injury,transplant rejection and immune tolerance.A good animal model of LT is essential for such innovation in transplant research.Although rat LT model has been used since the last century,it has never been an ideal model because the results observed in rat may not be applied to human because these two species are genetically distinct from each other.In this study,we for the first time performed LT using the tree shrew (Tupaia belangeri),a species in the Order Scandentia which is closely related with primates,and evaluated the possibility to adopt this species as a new model of LT.We performed LT on 30 animals using the two-cuff technique, examining the success rate,the survival rate and the immunological reaction.The recipient operation time was 60 min averagely,and we limited the time of the anhepatic phase within 20 min.Twenty-seven (90%)of the animals survived for at least 3 days after the transplantation. Thirteen animals that did not receive any immunosuppressive drug died in 8 days mostly because of acute rejection effect (n=9),similar to the reaction in human but not in experimental rat.The rest 14 animals that were given rapamycin survived significantly longer (38 days)and half of them survived for 60 days until the end of the study.Our results suggest that performing LT in tree shrews can yield high success rate and high survival rate.More importantly,the tree shrews share similar immunological reaction with human.In addition,previous genomics study found that the tree shrews share more proteins with human.In sum,the tree shrews may outperform the experimental rats and could be used as a better and cost-effective animal model for LT. 展开更多
关键词 liver TRANSPLANTATION TREE SHREW ANIMAL model ACUTE REJECTION
下载PDF
供体来源半成熟树突状细胞诱导大鼠肝移植术后免疫低反应的实验研究 被引量:1
2
作者 李春满 王伟 +5 位作者 张捷 唐波 李刚 董丽英 朱磊 付必莽 《中国现代医学杂志》 CAS 北大核心 2017年第16期18-23,共6页
目的研究供体来源半成熟树突状细胞(smDC)诱导大鼠肝移植术后免疫低反应的效果,初步分析其作用机制。方法该实验在成功完成大鼠树突状细胞(DC)培养和鉴定的基础上,进行大鼠肝移植术前输注供体来源DC、术后使用雷帕霉素灌胃,观察大鼠术... 目的研究供体来源半成熟树突状细胞(smDC)诱导大鼠肝移植术后免疫低反应的效果,初步分析其作用机制。方法该实验在成功完成大鼠树突状细胞(DC)培养和鉴定的基础上,进行大鼠肝移植术前输注供体来源DC、术后使用雷帕霉素灌胃,观察大鼠术后血清白细胞介素10(IL-10)和γ干扰素(IFN-γ)、CD4^+CD25^+Treg的变化,并评估急性免疫排斥病理改变。结果使用雷帕霉素后,可以改变血清细胞因子的分泌水平、促进Lewis→BN大鼠肝移植术后CD4^+CD25^+Treg的增殖,减轻术后免疫排斥反应,从而延长Lewis→BN大鼠肝移植术后生存时间。结合术前输注未成熟树突状细胞(imDC)或smDC,可以增强雷帕霉素的相应作用,进一步诱导大鼠肝移植术后免疫低反应,且smDC的作用强于imDC。结论 smDC可以诱导Lewis→BN大鼠肝移植术后免疫低反应。 展开更多
关键词 肝移植 半成熟树突状细胞 免疫排斥 调节性T细胞
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部